Effects of Teriparatide, Denosumab, or Both on Spine Trabecular Microarchitecture in DATA-Switch: a randomized controlled trial

In postmenopausal women, 2-years of combined teriparatide and denosumab increases bone mineral density (BMD) more than either drug alone and switching from either combination or teriparatide to denosumab for an additional 2-years further increases BMD. Conversely switching from denosumab to teripara...

全面介紹

Na minha lista:
書目詳細資料
發表在:J Clin Densitom
Main Authors: Tsai, JN, Jiang, LA, Lee, H, Hans, D, Leder, BZ
格式: Artigo
語言:Inglês
出版: 2017
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5673584/
https://ncbi.nlm.nih.gov/pubmed/28624340
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jocd.2017.05.007
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍